(HealthDay)—For patients undergoing percutaneous coronary intervention, ticagrelor monotherapy following three months of dual antiplatelet therapy significantly reduces clinically relevant bleeding compared with ticagrelor ...
Jul 7, 2021
0
5
Patients with a wide range of cancers who take aspirin as part of their treatment could help to reduce their risk of death by 20%, a major review of existing research has suggested.
Jul 2, 2021
0
174
(HealthDay)—Many older adults are still taking a daily baby aspirin to ward off first-time heart problems—despite guidelines that now discourage it, a new study finds.
Jun 22, 2021
0
12
The RECOVERY trial was established as a randomized clinical trial to test a range of potential treatments for patients hospitalized with COVID-19.
Jun 9, 2021
0
0
Clopidogrel outperformed aspirin in what is believed to be the first and largest randomized trial to compare the effectiveness of the two antiplatelet drugs as long-term maintenance therapy for patients who had no adverse ...
May 17, 2021
0
4
Rivaroxaban, in addition to low-dose aspirin, significantly reduced the occurrence of total severe events of the heart, limb or brain and issues related to other vascular complications in patients with symptomatic peripheral ...
May 17, 2021
0
3
An unusual study that had thousands of heart disease patients enroll themselves and track their health online as they took low- or regular-strength aspirin concludes that both doses seem equally safe and effective for preventing ...
May 16, 2021
1
196
Mother's Day is a happy day for millions, but for those who have experienced a miscarriage, the day can be devastating. As many as one in four recognized pregnancies result in miscarriage.
May 6, 2021
1
2
More blood thinners aren't automatically better, another study confirms.
Apr 19, 2021
0
11
New research offers insight into why regular, long-term use of low-dose aspirin may reduce the risk of death from colon and rectal cancers.
Mar 31, 2021
0
29
